Black Box and Nokia Team Up to Create OnGo Private Wireless/CBRS Network for Industry 4.0
3.11.2021 15:00:00 EET | Business Wire | Press release
Black Box, a leading global solutions integrator, announced today that it has joined with industry wireless communications innovator Nokia to provide the most complete, next-generation OnGo® private wireless/CBRS network for Industry 4.0. The partnership allows Black Box to drive innovation in connectivity and the adoption of private networks, giving the industrial manufacturing market superior options for wireless networking. Black Box explains that OnGo® — an even-licensed, low-band wireless spectrum that gives manufacturers access to private wireless connectivity at a fraction of the cost associated with LTE — mirrors the simplicity of Wi-Fi while providing secure, cost-effective LTE coverage for enterprise wireless traffic and IoT applications.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211103005142/en/
“Nokia welcomes Black Box to our Global Partner Program to help meet growing demand for private 4G/5G campus networks,” said Vikas Trehan, vice president, channels and alliances for Nokia. “Black Box’s intimate knowledge and trusted relationships within these enterprise campus networks, combined with world-class products and services from Nokia, will help realize the Industry 4.0 vision.”
“Private wireless and emerging private 5G networks are poised to redefine the corporate wireless networking space. Large campuses and sites like airports and large logistics and distribution hubs are pushing current WLAN standards to their technological limits,” said Bill Holman, vice president and general manager of 5G technologies at Black Box. “Thanks to our partnership with Nokia, sites like those can now break free from the limitations of WLAN and get exactly the wireless connectivity they need.”
Black Box designs, builds, and manages a full range of wireless technologies to support connected enterprise, delivering digital workplace connectivity across multiple industries. Leading manufacturers turn to Black Box to help incorporate OnGo® and 5G into their existing and future wireless networks. With Nokia Digital Automation Cloud (DAC) end-to-end private wireless, Black Box helps clients realize the full potential of Industry 4.0.
Further information about Black Box and the company’s global solutions integration services offerings is available at www.blackbox.com.
About Nokia
As a trusted partner for critical networks, we are committed to innovation and technology leadership across mobile, fixed and cloud networks with intellectual property and long-term research led by the award-winning Nokia Bell Labs. Nokia Digital Automation Cloud is a high-performance, LTE/5G end-to-end private wireless networking and edge computing platform. Delivering secure, plug and play, reliable wireless connectivity, Nokia DAC enables industrial use-cases leveraging real-time data for smart manufacturing, predictive maintenance, remote operations and Industrial Internet of Things (IoT) opportunities.
About Black Box
Black Box® is a trusted IT solutions provider delivering cutting-edge technology solutions and world-class consulting services to businesses on every continent. The breadth of our global reach and depth of expertise accelerate customer success by bringing people, ideas, and technology together to solve real-world business problems. Our IT infrastructure solutions, services, and products enable secure, flawless connectivity and meaningful collaboration across town or around the globe.
Black Box is a wholly owned subsidiary of AGC Networks. To learn more, visit the Black Box website at www.blackbox.com. Follow the company on Twitter @BlackBox_ns. Black Box® and the Double Diamond logo are registered trademarks of BB Technologies Inc.
All other trademarks referenced herein are the property of their respective owners.
PR Link: www.wallstcom.com/BlackBox/211103-Black_Box-Nokia_Partnership.docx
Photo: www.wallstcom.com/BlackBox/BlackBox-Nokia_OnGo-Private_Wireless_Network.jpg
Black Box and Nokia Team Up to Create OnGo® Private Wireless/CBRS Network for Industry 4.0
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211103005142/en/
Contact information
Black Box:
Cristine Kimbrel
Sr. Product Manager | 5G & OnGo
+1.724.873.7044
cristine.kimbrel@BlackBox.com
Nokia:
Evan Forrest
Global Industrial Partner Manager for Nokia
+1.925.413.0015
evan.forrest@nokia.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Datavault AI Announces Board of Directors Has Requested Management’s Complete Plan for Dividend Spin-Out of Acoustic Sciences Division into Stand-Alone Public Company7.5.2026 16:07:00 EEST | Press release
Datavault AI Inc. (“Datavault AI” or the “Company”) (NASDAQ:DVLT), a pioneering technology licensing company seeking to redefine data valuation, monetization, and secure Web 3.0 experiences, today announced that Company management has commenced its evaluation of a potential dividend spin-out of the Company’s Acoustic Sciences division which includes its ADIO®, WiSA®, Event Citadel™, and API Media operations into a new stand-alone public company, which is proposed to be named “API Media”. The Company has reserved the ticker symbol “ADIO” for the proposed spin-out entity and currently intends that API Media will be listed on NASDAQ following completion of the proposed transactions, which remain subject to approval by the Company’s board of directors, definitive agreement, and satisfaction of closing conditions, as well as any regulatory approvals that may be required in connection therewith. The Company has engaged Houlihan Lokey as its financial advisor and Paul Hastings LLP as its lega
Incyte Announces 24-Week Long-Term Data from Phase 3 TRuE-AD4 Trial of Opzelura ® (ruxolitinib) Cream in Adults with Moderate Atopic Dermatitis7.5.2026 15:50:00 EEST | Press release
Incyte (Nasdaq:INCY) today announced final 24-week data from the Phase 3 TRuE-AD4 study evaluating the efficacy and safety of Opzelura® (ruxolitinib) cream in adults with moderate atopic dermatitis (AD) who had an inadequate response, intolerance or contraindication to topical corticosteroids (TCSs) and topical calcineurin inhibitors (TCIs). These data were presented (Abstract ID: P0851) today at the 2026 European Academy of Dermatology and Venereology (EADV) Symposium, being held May 7–9, 2026, in Athens, Greece. As previously reported, the TRuE-AD4 study met both of its co-primary endpoints at Week 8, with a statistically significantly higher proportion of patients on Opzelura versus vehicle cream achieving EASI75 (≥75% improvement in Eczema Area and Severity Index score from baseline) and, separately, IGA-TS (Investigator's Global Assessment Treatment Success, defined as an IGA score of 0 [clear] or 1 [almost clear] with at least a two-point improvement from baseline).1 Patients who
Rapid Medical™’s TIGERTRIEVER™ 13 Demonstrates Promising 90-Day Outcomes in DISTALS Trial, Reinforcing Pivotal Safety and Efficacy Findings7.5.2026 15:03:00 EEST | Press release
Rapid Medical™, a leading developer of advanced stroke treatment devices, today announced full results from the DISTALS randomized clinical trial, presented at the 11th European Stroke Organisation Conference (ESOC) in Maastricht, Netherlands, showing that TIGERTRIEVER™ 13 can safely restore blood flow to the brain and may improve clinical outcomes in patients with distal and medium vessel occlusion (DMVO) stroke. These findings build on earlier results showing a threefold improvement in restoring blood flow compared with medical management alone (p<0.0001), with no cases of serious brain bleeding observed in the treatment group. “These results show we can now safely restore blood flow and suggest this will make a meaningful difference for the right patients,” said Jeffrey L. Saver, MD, UCLA, and Principal Investigator of DISTALS. “What’s important is that both the device and the trial were designed specifically for distal stroke. By using a device built for these small vessels and mea
2 Million Downloads in Six Months: Tabelog’s Multilingual App Solves Critical Dining Pain Points for Travelers to Japan7.5.2026 15:00:00 EEST | Press release
Tabelog (https://tabelog.com/en/), one of Japan’s largest (*1) restaurant search and reservation services operated by Kakaku.com, Inc., has announced that its multilingual smartphone app (iOS/Android) for travelers visiting Japan has reached 2 million downloads (*2). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260507560248/en/ 2M+ Downloads in 6 Months. The app also ranked #1 in downloads among Restaurant Search Apps in Japan for International Travelers (*3) in Taiwan, Hong Kong, South Korea, and the U.S., reflecting its immense popularity among global visitors. Download URL: https://tabelog-tourists.onelink.me/3eEh/iqkkho9r The Trusted Choice for Global Travelers: Solving Two Major Dining Pain Points in Japan For years, international visitors to Japan have faced two critical dining pain points: [Pain Point 1] The Information Gap: Most available resources are tailored for tourists, making it difficult to find the true loc
Altasciences and Certara Announce Strategic Partnership to Accelerate Early Drug Development7.5.2026 15:00:00 EEST | Press release
Altasciences, a fully integrated drug development solution company, andCertara (Nasdaq: CERT), a global leader in model-informed drug development (MIDD), today announced a strategic partnership to accelerate early-phase development programs. Fewer than half of preclinical drug candidates successfully reach first-in-human trials. Failures are driven by toxicity, poor pharmacokinetics, lack of efficacy, and challenges translating results from animals to humans. Many of these risks can be mitigated through a fully integrated model-informed drug development approach. Building on Altasciences’ Acceleration Platform, the integration of Certara’s strategic drug development services and biosimulation technology enables sponsors to establish proof of mechanism earlier, design more efficient studies, and make informed go/no-go decisions with greater confidence. By embedding modeling insights and digital workflows directly into development execution, study designs are optimized, dosing strategies
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom